ID   SK-L9
AC   CVCL_LK93
SY   SKL-9; SKL9
DR   Wikidata; Q54953690
RX   PubMed=3518877;
RX   PubMed=4170382;
RX   PubMed=4894370;
RX   PubMed=5229525;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
RX   PubMed=3518877; DOI=10.3109/07357908609038260;
RA   Fogh J.;
RT   "Human tumor lines for cancer research.";
RL   Cancer Invest. 4:157-184(1986).
//
RX   PubMed=4170382;
RA   Clarkson B.D. Sr.;
RT   "On the cellular origins and distinctive features of cultured cell
RT   lines derived from patients with leukemias and lymphomas.";
RL   Cancer Res. 27:2483-2488(1967).
//
RX   PubMed=4894370; DOI=10.1002/1097-0142(196908)24:2<211::AID-CNCR2820240202>3.0.CO;2-3;
RA   Southam C.M., Burchenal J.H., Clarkson B.D. Sr., Tanzi A., Mackey R.,
RA   McComb V.;
RT   "Heterotransplantability of human cell lines derived from leukemia and
RT   lymphomas into immunologically tolerant rats.";
RL   Cancer 24:211-222(1969).
//
RX   PubMed=5229525; DOI=10.1002/1097-0142(196706)20:6<926::AID-CNCR2820200603>3.0.CO;2-4;
RA   Clarkson B.D. Sr., Strife A., de Harven E.;
RT   "Continuous culture of seven new cell lines (SK-L1 to 7) from patients
RT   with acute leukemia.";
RL   Cancer 20:926-947(1967).
//